ArticleMolecular oncology2018

Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner.

Konstantinos Dimopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.